[Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
D001667:Binding, Competitive; D002927:Cimetidine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000517:prevention & control; D005663:Furans / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008134:Long-Term Care; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000517:prevention & control; D011899:Ranitidine; D012008:Recurrence; D013276:Stomach Ulcer / Q000188:drug therapy / Q000517:prevention & control
D005663:Furans; D006635:Histamine H2 Antagonists; D002927:Cimetidine; D011899:Ranitidine
Therapie und Prophylaxe des Ulcus duodeni et ventriculi mit Histamin-H2-Rezeptorantagonisten.